Mendra
San Francisco, California, United States · Biotechnology, Health Care · 2 employees
Mendra is a biopharmaceutical company focused on improving the development and commercialization of rare disease therapies worldwide. Founded in 2025, it utilizes AI to address long-standing challenges in patient identification, data curation, and clinical development for rare diseases. Mendra aims to streamline the drug development process to accelerate access to innovative treatments for underse
Funding history
- Series series a — $82.0M — Jan 2026
Recent signals
- Jan 22, 2026: Raised $82.0M in Series series a
See plans & pricing → Track Mendra’s funding, hiring, and signals — with verified contacts — on Fundz.